Auf der Suche nach (Reverse) M&A´s - 500 Beiträge pro Seite
eröffnet am 17.10.07 23:09:52 von
neuester Beitrag 25.10.07 08:42:11 von
neuester Beitrag 25.10.07 08:42:11 von
Beiträge: 5
ID: 1.134.089
ID: 1.134.089
Aufrufe heute: 0
Gesamt: 444
Gesamt: 444
Aktive User: 0
Top-Diskussionen
Titel | letzter Beitrag | Aufrufe |
---|---|---|
vor 25 Minuten | 5245 | |
vor 28 Minuten | 4369 | |
vor 34 Minuten | 3591 | |
heute 13:40 | 3024 | |
vor 1 Stunde | 2284 | |
vor 1 Stunde | 1901 | |
vor 51 Minuten | 1638 | |
heute 13:07 | 1348 |
Meistdiskutierte Wertpapiere
Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
---|---|---|---|---|---|---|---|
1. | 1. | 18.163,03 | +1,30 | 225 | |||
2. | 2. | 1,1000 | -20,29 | 119 | |||
3. | 3. | 0,1905 | +0,79 | 105 | |||
4. | 5. | 9,3250 | +0,87 | 76 | |||
5. | 4. | 168,02 | -1,27 | 57 | |||
6. | Neu! | 11,905 | +14,97 | 38 | |||
7. | Neu! | 4,8000 | +7,02 | 36 | |||
8. | Neu! | 0,4250 | -1,16 | 36 |
Dieser Thread soll sich in erster Linie damit beschäftigen, potenzielle M&A (Mergers & Acquisitions) Kandidaten zu suchen und diese zu durchleuchten. (Soweit es irgendwie möglich ist...) Es sollte darauf geachtet werden, dass kein 08/18 Schrott behandelt wird, der schon im vorhinein recht klar auf Pump&Dump Aktivitäten hindeutet, da keiner was davon haben würde.
Also, auf gutes Gelingen.
Also, auf gutes Gelingen.
Ich habe erstmal KDUS.OB (Cadus Corporation) im Angebot.
Overview:
Cadus Pharmaceutical had hoped to make some dough from yeast. Its drug discovery technologies used genetically engineered yeast cells, but the firm sold its discovery programs to OSI Pharmaceuticals and is looking for new opportunities. The company even dropped "Pharmaceutical" from its name to signal its interest in acquisitions outside the biotech industry. Its subsidiary Cadus Technologies still holds some assets related to its yeast cell technology and is seeking interested parties to license the intellectual properties.
Ausserdem besitzt KDUS ein total stockholders’ equity Posten von $25,934,708, der sich auf cash und cash equivalents zurückführen lässt. Des weiteren haben wir es in den letzten Monaten mit großen Insiderkäufen zu tun.
Die Marktkapitalisierung beträgt im Moment $25,36 Millionen, bei 13,144,040 outstanding shares.
Overview:
Cadus Pharmaceutical had hoped to make some dough from yeast. Its drug discovery technologies used genetically engineered yeast cells, but the firm sold its discovery programs to OSI Pharmaceuticals and is looking for new opportunities. The company even dropped "Pharmaceutical" from its name to signal its interest in acquisitions outside the biotech industry. Its subsidiary Cadus Technologies still holds some assets related to its yeast cell technology and is seeking interested parties to license the intellectual properties.
Ausserdem besitzt KDUS ein total stockholders’ equity Posten von $25,934,708, der sich auf cash und cash equivalents zurückführen lässt. Des weiteren haben wir es in den letzten Monaten mit großen Insiderkäufen zu tun.
Die Marktkapitalisierung beträgt im Moment $25,36 Millionen, bei 13,144,040 outstanding shares.
Es sollte natürlich 08/15 heißen und nicht 08/18.
CADWF (China Discovery Acquisition Corp.)
Overview:
China Discovery Acquisition Corp. (the “Company”) was incorporated in the Cayman Islands on January 8, 2007 as a blank check company whose objective is to acquire, through a stock exchange, asset acquisition or other similar business combination, an operating business, or control of such operating business through contractual arrangements, that has its principal operations located in the People’s Republic of China.
On June 26, 2007, we consummated our initial public offering of 5,000,000 Units, with each unit consisting of one ordinary share and two warrants, each to purchase one ordinary share at an exercise price of $5.00 per share. On July 2, 2007, we closed on an additional 750,000 units that were subject to the underwriters’ over-allotment option. The units were sold at an offering price of $6.00 per unit, generating total gross proceeds of $34,500,000. Simultaneously with the consummation of our initial public offering, we consummated the private sale of 105,000 units at $6.00 per unit and 1,033,334 warrants at $0.60 per warrant to certain of our initial stockholders and affiliates for an aggregate purchase price of $1,250,000. EarlyBirdCapital, Inc. acted as lead underwriter. The securities sold in the offering were registered under the Securities Act of 1933 on a registration statement on Form S-1 (No. 333-140516). The Securities and Exchange Commission declared the registration statement effective on June 18, 2007.
We paid a total of $2,031,456 in underwriting discounts and commissions and costs and expenses related to the offering.
After deducting the underwriting discounts and commissions and the offering expenses, the total net proceeds to us from the offering were approximately $29,075,000, of which $29,075,000 was deposited into the trust account and the remaining proceeds are available to be used to provide for business, legal and accounting due diligence on prospective business combinations and continuing general and administrative expenses. In addition, all of the proceeds from the private sale of the units and warrants were deposited into the Trust Fund, for a total of $33,372,500 (or approximately $5.80 per share sold in the offering).
Authorized 25,000,000 shares, 7,105,000 shares issued and outstanding + warrants
Overview:
China Discovery Acquisition Corp. (the “Company”) was incorporated in the Cayman Islands on January 8, 2007 as a blank check company whose objective is to acquire, through a stock exchange, asset acquisition or other similar business combination, an operating business, or control of such operating business through contractual arrangements, that has its principal operations located in the People’s Republic of China.
On June 26, 2007, we consummated our initial public offering of 5,000,000 Units, with each unit consisting of one ordinary share and two warrants, each to purchase one ordinary share at an exercise price of $5.00 per share. On July 2, 2007, we closed on an additional 750,000 units that were subject to the underwriters’ over-allotment option. The units were sold at an offering price of $6.00 per unit, generating total gross proceeds of $34,500,000. Simultaneously with the consummation of our initial public offering, we consummated the private sale of 105,000 units at $6.00 per unit and 1,033,334 warrants at $0.60 per warrant to certain of our initial stockholders and affiliates for an aggregate purchase price of $1,250,000. EarlyBirdCapital, Inc. acted as lead underwriter. The securities sold in the offering were registered under the Securities Act of 1933 on a registration statement on Form S-1 (No. 333-140516). The Securities and Exchange Commission declared the registration statement effective on June 18, 2007.
We paid a total of $2,031,456 in underwriting discounts and commissions and costs and expenses related to the offering.
After deducting the underwriting discounts and commissions and the offering expenses, the total net proceeds to us from the offering were approximately $29,075,000, of which $29,075,000 was deposited into the trust account and the remaining proceeds are available to be used to provide for business, legal and accounting due diligence on prospective business combinations and continuing general and administrative expenses. In addition, all of the proceeds from the private sale of the units and warrants were deposited into the Trust Fund, for a total of $33,372,500 (or approximately $5.80 per share sold in the offering).
Authorized 25,000,000 shares, 7,105,000 shares issued and outstanding + warrants
Antwort auf Beitrag Nr.: 32.140.505 von benefactor am 24.10.07 21:51:54Beim oberen Chart handelt es sich fälschlicherweise nur um die China Discovery Acquisition Corp. warrants. Das hier ist nätürlich der richtige. Die China Discovery Acquisition Corp. units werden übrigens unter CADUF.OB gehandelt.
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
240 | ||
113 | ||
107 | ||
73 | ||
57 | ||
39 | ||
37 | ||
36 | ||
34 | ||
31 |
Wertpapier | Beiträge | |
---|---|---|
27 | ||
23 | ||
19 | ||
18 | ||
18 | ||
18 | ||
17 | ||
17 | ||
16 | ||
16 |